These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Effects of glibenclamide on mRNA level of ATP-sensitive potassium channels of heart in normal and streptozotocin-induced diabetic rats].
    Author: Li Y, Deng Q, Fu Z.
    Journal: Zhonghua Yi Xue Za Zhi; 2000 Jul; 80(7):538-40. PubMed ID: 11798815.
    Abstract:
    OBJECTIVE: To estimate if any difference exists in mRNA expression levels of KATP (SUR1, SUR2, Kir6.2) in heart tissues between streptozotocin-induced diabetic and normal rats, and to examine if any changes of heart KATP in mRNA level occurred after long-term Glibenclamide administration among the diabetic and control rats. METHODS: Part 1: Adult male Sprague-Dawley (SD) rats were allocated into three groups: one group (n = 13) was taken as normal control, and the other two groups were diabetic models induced by a single intraperitoneal injection of streptozotocin (60 mg/kg). One of the diabetic groups (n = 10) was treated with premixed insulin (30%RI, 70%NPH) 4 - 8 units/day by subcutaneous injection at 4 - 5 pm everyday for two weeks. Part 2: Four groups of adult male SD rats were enrolled into the study. Group one (D1) was diabetes control induced by streptozotocin (n = 9), group two (DG2) was the diabetes treated with Glibenclamide (n = 14). Group three (N3) was normal control (n = 10), and group four (NG4) received Glibenclamide administration without diabetes (n = 14). DG2 and NG4 were given 10 mg/kg Glibenclamide intraperitonealy at 4 - 5 pm everyday for 14 days. Single-stranded digoxigenin-labeled probes were generated with RT-PCR. A total of 30 microgram of unfractionated RNA was transferred onto nylon membranes by dot-blot. Hybridization was performed at 50 degrees C for 16 hours with high SDS concentration hybridization buffer. RESULTS: Study one: There was no significant difference in mRNA expression levels of SUR1, SUR2, and Kir6.2 in heart between diabetic, insulin-treated diabetic and control groups (P > 0.05). Study two: Glibenclamide-treated non-diabetic rats had higher mRNA expression levels of SUR1 and SUR2 in heart than normal control. The SUR1 were 43.0 +/- 16.6 vs 30.8 +/- 7.8 (P < 0.05), SUR2 161.9 +/- 51.0 vs 118.9 +/- 40.9 (P < 0.05), respectively. No difference in heart Kir6.2 mRNA level was found between the two groups (P > 0.05). Comparison between Glibenclamide-treated diabetic and non-treated diabetic rats showed that there was no change in mRNA levels of SUR1, SUR2 and Kir6.2 in heart (P > 0.05). CONCLUSION: Chronic Glibenclamide-treatment up-regulates KATP gene transcriptional expression of heart in non-diabetic rats. The Streptozotocin-inducing diabetes itself does not affect the mRNA expression of KATP (SUR1, SUR2, and Kir6.2) in extra-pancreas tissues, but decreases the response of KATP to chronic Glibenclamide-treatment at transcriptional level.
    [Abstract] [Full Text] [Related] [New Search]